Your browser doesn't support javascript.
Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.
Jain, Arihant; Nayak, Lingaraj; Kulkarni, Uday Prakash; Mehra, Nikita; Yanamandra, Uday; Kayal, Smita; Damodar, Sharat; John, Joseph M; Mehta, Prashant; Singh, Suvir; Munot, Pritesh; Selvarajan, Sushil; Radhakrishnan, Venkatraman; Lad, Deepesh; Kapoor, Rajan; Dubashi, Biswajit; Bharath, Ram S; Jain, Hasmukh; Jayachandran, P K; Lakshmanan, Jeyaseelan; Mani, Thenmozhi; Thorat, Jayashree; Das, Satyaranjan; Karunamurthy, Omprakash; George, Biju; Sengar, Manju; Malhotra, Pankaj.
  • Jain A; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Nayak L; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.
  • Kulkarni UP; Department of Haematology, Christian Medical College, Vellore, India.
  • Mehra N; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India.
  • Yanamandra U; Army Hospital (Research & Referral), New Delhi, India.
  • Kayal S; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
  • Damodar S; Department of Haematology, Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India.
  • John JM; Department of Clinical Haematology-Oncology and Bone Marrow(Stem Cell) Transplantation, Christian Medical College, Ludhiana, India.
  • Mehta P; Department of Medical Oncology, Asian Institute, Faridabad, India.
  • Singh S; Department of Clinical Haematology, Dayanand Medical College, Ludhiana, India.
  • Munot P; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.
  • Selvarajan S; Department of Haematology, Christian Medical College, Vellore, India.
  • Radhakrishnan V; Department of Medical Oncology, Cancer Institute (WIA), Chennai, India.
  • Lad D; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Kapoor R; Army Hospital (Research & Referral), New Delhi, India.
  • Dubashi B; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
  • Bharath RS; Department of Haematology, Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India.
  • Jain H; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.
  • Jayachandran PK; Department of Haematology, Christian Medical College, Vellore, India.
  • Lakshmanan J; Department of Biostatistics, Christian Medical College, Vellore, India.
  • Mani T; Department of Biostatistics, Christian Medical College, Vellore, India.
  • Thorat J; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.
  • Das S; Army Hospital (Research & Referral), New Delhi, India.
  • Karunamurthy O; Department of Biostatistics, Christian Medical College, Vellore, India.
  • George B; Department of Haematology, Christian Medical College, Vellore, India.
  • Sengar M; Adult Haematolymphoid Disease Management Group, Tata Memorial Centre, Mumbai, India.
  • Malhotra P; Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. malhotrapankaj@hotmail.com.
Blood Cancer J ; 12(1): 2, 2022 01 05.
Article in English | MEDLINE | ID: covidwho-1605546
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Blood Cancer J Year: 2022 Document Type: Article Affiliation country: S41408-021-00599-w

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematologic Neoplasms / COVID-19 Type of study: Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Blood Cancer J Year: 2022 Document Type: Article Affiliation country: S41408-021-00599-w